PMS33 COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE PREVIOUS DMARD THERAPY IN MEXICO
Abstract
Authors
F Carlos A Aguirre I Pelez-Ballestas
F Carlos A Aguirre I Pelez-Ballestas
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now